MORRISVILLE, N.C., juillet 18, 2022 (GLOBE NEWSWIRE) -- Syneos Health^® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its second quarter 2022 financial results on mardi, août 2, 2022, prior to its earnings call at 9:00 a.m. ET.

Participants may access the conference call live via webcast on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com.

To participate in the conference, please register in advance at this link. Upon registration, all participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.

A webcast replay will be available on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com after 1:00 p.m. on août 2, 2022.

About Syneos Health
Syneos Health^® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. Nous menons nos activités dans une optique de développement de produits, en associant stratégiquement le développement clinique, les affaires médicales et les activités commerciales pour répondre aux réalités du marché moderne.

We bring together more than 29,000 minds, across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Ensemble, nous partageons des connaissances, utilisons les dernières technologies et appliquons des pratiques commerciales de pointe pour accélérer la livraison d’importants traitements par nos clients aux patients.

Syneos Health soutient une culture diversifiée, équitable et inclusive qui prend soin des collègues, des clients, des patients, des collectivités et de l’environnement.

To learn more about how we are Shortening the distance from lab to life^®, visit syneoshealth.com or subscribe to our podcast.